263 related articles for article (PubMed ID: 36291127)
1. Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP.
Nagaraj K; Sarfstein R; Laron Z; Werner H
Cells; 2022 Oct; 11(20):. PubMed ID: 36291127
[TBL] [Abstract][Full Text] [Related]
2. Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action.
Nagaraj K; Lapkina-Gendler L; Sarfstein R; Gurwitz D; Pasmanik-Chor M; Laron Z; Yakar S; Werner H
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1045-1050. PubMed ID: 29339473
[TBL] [Abstract][Full Text] [Related]
3. TXNIP regulates AKT-mediated cellular senescence by direct interaction under glucose-mediated metabolic stress.
Huy H; Song HY; Kim MJ; Kim WS; Kim DO; Byun JE; Lee J; Park YJ; Kim TD; Yoon SR; Choi EJ; Lee CH; Noh JY; Jung H; Choi I
Aging Cell; 2018 Dec; 17(6):e12836. PubMed ID: 30168649
[TBL] [Abstract][Full Text] [Related]
4. Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.
Sarfstein R; Nagaraj K; Parikh S; Levy C; Laron Z; Benayahu D; Werner H
Cells; 2022 May; 11(10):. PubMed ID: 35626664
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.
Yaron-Saminsky D; Nagaraj K; Sarfstein R; Laron Z; Pasmanik-Chor M; Werner H
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769292
[TBL] [Abstract][Full Text] [Related]
6. The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway.
Shibel R; Sarfstein R; Nagaraj K; Lapkina-Gendler L; Laron Z; Dixit M; Yakar S; Werner H
Cells; 2021 Jun; 10(6):. PubMed ID: 34204736
[TBL] [Abstract][Full Text] [Related]
7. Identification of nephronectin as a new target for IGF1 action.
Sarfstein R; Lapkina-Gendler L; Nagaraj K; Laron Z; Werner H
Eur J Cancer; 2020 Dec; 141():115-127. PubMed ID: 33130549
[TBL] [Abstract][Full Text] [Related]
8. Identification of signaling pathways associated with cancer protection in Laron syndrome.
Lapkina-Gendler L; Rotem I; Pasmanik-Chor M; Gurwitz D; Sarfstein R; Laron Z; Werner H
Endocr Relat Cancer; 2016 May; 23(5):399-410. PubMed ID: 27090428
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways.
Werner H; Lapkina-Gendler L; Achlaug L; Nagaraj K; Somri L; Yaron-Saminsky D; Pasmanik-Chor M; Sarfstein R; Laron Z; Yakar S
Cells; 2019 Jun; 8(6):. PubMed ID: 31208077
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte-specific Txnip C247S mutation improves left ventricular functional reserve in streptozotocin-induced diabetic mice.
Mukai N; Nakayama Y; Abdali SA; Yoshioka J
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H259-H274. PubMed ID: 34085839
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
[TBL] [Abstract][Full Text] [Related]
12. TXNIP Exacerbates the Senescence and Aging-Related Dysfunction of β Cells by Inducing Cell Cycle Arrest Through p38-p16/p21-CDK-Rb Pathway.
Li Y; Deng W; Wu J; He Q; Yang G; Luo X; Jia Y; Duan Y; Zhou L; Liu D
Antioxid Redox Signal; 2023 Mar; 38(7-9):480-495. PubMed ID: 36070438
[No Abstract] [Full Text] [Related]
13. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange.
Patwari P; Higgins LJ; Chutkow WA; Yoshioka J; Lee RT
J Biol Chem; 2006 Aug; 281(31):21884-21891. PubMed ID: 16766796
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factors and aging: lessons from Laron syndrome.
Werner H; Laron Z
Front Endocrinol (Lausanne); 2023; 14():1291812. PubMed ID: 37941907
[TBL] [Abstract][Full Text] [Related]
15. Congenital IGF-1 deficiency protects from cancer: lessons from Laron syndrome.
Laron Z; Werner H
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37343154
[TBL] [Abstract][Full Text] [Related]
16. Txnip C247S mutation protects the heart against acute myocardial infarction.
Nakayama Y; Mukai N; Wang BF; Yang K; Patwari P; Kitsis RN; Yoshioka J
J Mol Cell Cardiol; 2021 Jun; 155():36-49. PubMed ID: 33652022
[TBL] [Abstract][Full Text] [Related]
17. Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation.
Werner H; Sarfstein R; Nagaraj K; Laron Z
Cells; 2020 Nov; 9(11):. PubMed ID: 33182502
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
19. [Effect of diabetic induced thioredoxin interacting protein (TXNIP) on islet cell senescence].
Huo HY; Wang J; Zhang XM; Zhang WT; Yue JP; Jiao XY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Mar; 36(2):119-123. PubMed ID: 32744003
[No Abstract] [Full Text] [Related]
20. Role and mechanism of TXNIP in ageing-related renal fibrosis.
He Q; Li Y; Zhang W; Chen J; Deng W; Liu Q; Liu Y; Liu D
Mech Ageing Dev; 2021 Jun; 196():111475. PubMed ID: 33781783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
